Published on 5 Mar 2024 on Benzinga
Avadel Pharmaceuticals Analysts Increase Their Forecasts After Q4 Results - Avadel Pharmaceuticals...
Avadel Pharmaceuticals plc AVDL reported better-than-expected fourth-quarter revenue results and also issued a corporate update on Monday.
Avadel Pharmaceuticals posted a quarterly loss of 32 cents per share, compared to market expectations for a loss of 29 cents per share. The company’s quarterly sales came in at $19.45 million versus estimates of $18.11 million, according to data from Benzinga Pro.